Evaluation of the Sysmex UF-4000i urine analyzer as a screening test to rule out urinary tract infection and reduce urine cultures.

Évaluation de l’analyseur Sysmex UF-4000i comme test de dépistage pour exclusion des infections urinaires et diminution des mises en culture

Journal

Annales de biologie clinique
ISSN: 1950-6112
Titre abrégé: Ann Biol Clin (Paris)
Pays: France
ID NLM: 2984690R

Informations de publication

Date de publication:
16 05 2023
Historique:
medline: 19 5 2023
pubmed: 5 5 2023
entrez: 5 5 2023
Statut: ppublish

Résumé

Urinary tract infection (UTI) diagnosis by urine culture is time- and labor- consuming. In the Ibn Rochd microbiology laboratory, up to 70% of urine culture samples yield no growth or insignificant growth. To evaluate the new generation of Sysmex UF-4000i fluorescence flow cytometry analyzer with a blue semiconducting laser as a method to rule out negative urine samples for UTI, in comparison of urine culture. Flow cytometry and microbiological analysis were performed on 502 urine samples included in the study. We used ROC analysis to determine cutoff points at which optimal sensitivity and specificity are achieved for clinical use. Our results showed that bacteria count at a cut-off of 100/μL, and/or the leucocytes count ≥ 45/μL are the optimal indicator for positive culture results. At these cut off, bacteria sensitivity (SE), specificity (SP), Positive predictive value (PPV) and negative predictive value (NPV) were 97,3%, 95%, 87,8% and 98,8% respectively. For leucocytes, SE, SP, PPV and NPV were 99,1%, 95,8%, 88,6% and 99,7% respectively. The bacterial and leucocytes counts generated by UF-4000i analysis may be useful in our context as a rapid screening to exclude UTI by reducing about 70% of urines cultures and then workload. Nevertheless, further validation is needed for different patient groups especially with urological disease or immunocompromised patients.

Identifiants

pubmed: 37144792
pii: abc.2023.1797
doi: 10.1684/abc.2023.1797
doi:

Types de publication

Journal Article

Langues

eng fre

Sous-ensembles de citation

IM

Pagination

156-161

Auteurs

Assiya El Kettani (A)

Bacteriology-Virology and Hospital Hygiene Laboratory, University Hospital Centre Ibn Rochd of Casablanca, Morocco, Department of Microbiology, Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Morocco.

Samy Housbane (S)

Laboratory of medical informatics, Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Morocco.

Fatima Wakit (F)

Bacteriology-Virology and Hospital Hygiene Laboratory, University Hospital Centre Ibn Rochd of Casablanca, Morocco, Department of Microbiology, Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Morocco.

Karima Arioua Mikou (KA)

Scientific Department, Megaflex SARL, Casablanca, Morocco.

Houria Belabbes (H)

Bacteriology-Virology and Hospital Hygiene Laboratory, University Hospital Centre Ibn Rochd of Casablanca, Morocco, Department of Microbiology, Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Morocco.

Khalid Zerouali (K)

Bacteriology-Virology and Hospital Hygiene Laboratory, University Hospital Centre Ibn Rochd of Casablanca, Morocco, Department of Microbiology, Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Morocco.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH